Introduction {#section0005}
============

Avian infectious bronchitis virus (IBV) is considered one of the major poultry pathogens, being probably endemic in all regions with intensive poultry production ([@bib38]). It is primarily a respiratory pathogen of domestic fowl, although strains can vary in pathogenicity and tissue tropism ([@bib23], [@bib24], [@bib51]). IBV is a Group 3 member in the genus Coronavirus ([@bib18]) and its genome consists of a 27 Kb single-stranded positive-sense RNA molecule that encodes for four structural proteins. The nucleoprotein (N) is associated with viral genome to form the nucleocapsid, whereas the remaining structural proteins, the spike (S), small membrane (M), and envelope proteins (E), are inserted in the envelope surrounding the nucleocapsid. In addition, the genome also encodes for the replicase complex responsible for carrying out the unique discontinuous transcription process that leads to the generation of a nested set of six 3′ and 5′ coterminal subgenomic mRNAs ([@bib45], [@bib46]).

The continuous emergence of new IBV serotypes has complicated the design of appropriate control programs due to the antigenic variation and the low degree of cross protection observed among IBV serotypes and has pointed out the necessity for accurate techniques to diagnose and classify this viral agent ([@bib13]). Nucleotide sequencing and subsequent genetic analysis of the S1 protein gene sequences provides a fast and accurate method to classify and predict IBV serotype, but also a powerful instrument to monitor phylogenetic and epidemiological evolution of IBV subtypes ([@bib1], [@bib7], [@bib9], [@bib10], [@bib25], [@bib26], [@bib31], [@bib32], [@bib34], [@bib36], [@bib49]). Mutation and recombination processes have been demonstrated to be involved in the genetic variation, and therefore in the evolution of IBV, leading to the emergence of new variant strains and giving rise to virus population diversity ([@bib8], [@bib27], [@bib30], [@bib50]). However, very distinct spatiotemporal and epidemiological behaviours are shown among these new strains. Whereas some emergent viruses rapidly spread to other geographic areas and become established, as happened with the 4/91 serotype in Europe or the Georgia serotype in North America, others remain restricted to the region of origin. More interestingly, hardly ever genotypes are exchanged among different continents ([@bib29], [@bib52]). Nevertheless, factors that determine distinct spreading and fitness abilities of the new emergent strains are poorly understood. Hence, monitoring IBV subpopulation dynamics in a specific region over time may reveal molecular features that contributed to the different fitting and spreading abilities of IBV strains.

IBV has been diagnosed in Spain since the early seventies by virus isolation and serological techniques. In 2002, an epidemiological survey among the most important Spanish poultry companies pointed out IB as one of the main infectious diseases affecting farms and revealed the necessity of an in-depth study to determine the epidemiological situation and to improve the efficacy of vaccination and control programs against the disease. Furthermore, the availability of IBV strains isolated in Spain during the past 14 years provided a unique opportunity for a detailed genetic study to determine not only the prevalent IBV genotypes in our country but also the dynamics of viral subpopulation which is necessary for a deeply understanding of IBV evolution and epidemiology.

In this study, twenty-six IB viruses isolated in Spain from clinical outbreaks occurring between 1992 and 2005 were molecularly characterized by sequencing the whole *S1* gene. To increase our insight into factors involved in IBV evolutionary process, specific tests to determine the presence of positive selection forces were carried out. Furthermore, several methods were implemented to identify putative recombination events among these isolates and establish the extent of recombination into IBV evolution. Finally, the antigenic relationships of the major genotypes identified in our country with reference strains were assessed by cross VN assays to ascertain the practical implications of molecular changes observed into virus immunogenicity.

Results {#section0010}
=======

S1 gene phylogenetic and sequence analyses revealed that four different genotypes have been present in Spain over the last 14 years {#section0015}
-----------------------------------------------------------------------------------------------------------------------------------

Phylogenetic analysis based on both *S1* gene nucleotide and amino acid deduced sequences of the twenty-six Spanish isolates and the reference IBV strains showed that Spanish isolates were separated into four distinct genetic groups or genotypes ([Fig. 1](#fig1){ref-type="fig"} ). Genotype I included thirteen out of the twenty-six field isolates, isolated between 1992 and 2000, that were grouped with 4/91 reference isolates. Seven Spanish field isolates, from 1997 to 2005, were included in genotype II, and showed maximum nucleotide and amino acid identities with Italy 02 strains. Genotype III comprised three field viruses isolated between 1996 and 2000 that were grouped with isolates of the Massachusetts serotype. Particularly, Spain/98/308 and Spain/00/339 isolates were grouped with Massachusetts vaccine strains (H120) in the phylogenetic tree, and they are likely to be reisolations of vaccine strains used in the immunization of those flocks. Finally, Spanish genotype IV included 3 isolates that split in a unique genetic group in the phylogenetic analysis. All viruses included in genotype IV were isolated in 1999 and showed maximum nucleotide and amino acid identities with Italy 02 isolates (90.6--92% and 89--91.1% respectively).Fig. 1Phylogenetic tree constructed by a maximum likelihood method (Tree-Puzzle 5.2). Nucleotide sequences of the complete *S1* gene of Spanish field isolates investigated in this study (in bold letters) and reference IBV strains obtained from GenBank database are included in the comparison.

Genetic studies of Spanish isolates of 4/91 genotype (genotype I) showed the presence of two distinct genetic clusters {#section0020}
----------------------------------------------------------------------------------------------------------------------

The 13 isolates assigned into the Spanish genotype I group shared maximum nucleotide and amino acid divergences of 7.3% and 10.3% respectively. Phylogenetic analyses comparing the complete *S1* gene sequences of the 13 Spanish genotype I field isolates and all 4/91 *S1* gene sequences previously published in the GenBank database, including British, French and Iranian isolates, revealed that Spanish isolates were clearly grouped in two separated genetic clusters identified as Spanish genotype I cluster 1 (including 11 isolates) and Spanish genotype I cluster 2 (including 2 isolates). Average nucleotide and amino acid identities shared by both clusters were 93.1% and 91.3% respectively. The minimum amino acid divergence observed between two isolates from the same year was 0.4% (between Spain/92/185 and Spain/92/51), whereas the maximum was 9.9% (between Spain/99/319 and Spain/99/327). Both cluster 1 and cluster 2 isolates showed maximum average nucleotide and amino acid identities with French isolate FR-94047-94. Comparison of 4/91 Spanish field isolates sequences revealed a common unique deletion at amino acid position 58 (located in HVR1) in 6 isolates included in cluster 1. Four isolates within this same group shared an amino acid deletion at position 340, located in HVR3. Both isolates included in cluster 2 showed 8 unique amino acid substitutions. In addition, isolate Spain/99/327 in cluster 2 showed 3 amino acid deletions at positions 55, 56 and 57 (located in HVR1). No cumulative changes were observed among 4/91 Spanish isolates.

Sequence analysis of Spanish isolates of Italy 02 genotype (Genotype II) clearly revealed presence of cumulative amino acid changes within S1 gene {#section0025}
--------------------------------------------------------------------------------------------------------------------------------------------------

A total of 11 Spanish field strains of Italy 02 genotype, seven from the present study and 4 previously described ([@bib14]), and the reference strain Italy 02 were included in the present study. Maximum nucleotide and amino acid divergence within Spanish Italy 02 isolates was 5.7% and 9.9%, respectively. The maximum amino acid distance between two viruses isolated the same year was 3.6% (Spain/04/5438 and Spain/04/221). No insertions or deletions were observed within *S1* gene sequences of the Spanish Italy 02 isolates, except for the Spain/98/313 that showed two deletions at amino acid positions 139 and 140. Analysis of the sequences showed that 12 amino acid positions were cumulative changes that become fixed in a progressive manner through time of isolation.

Sequence analysis of Spanish genotype IV (Spain/99/325) showed a drastic shift on sequence homology when 5′ and 3′ ends of S1 gene were compared {#section0030}
------------------------------------------------------------------------------------------------------------------------------------------------

*S1* gene sequences of genotype IV isolates were aligned and compared with the remainder Spanish field isolates and a total of 90 mutated amino acid positions were observed in genotype IV isolates with respect to Spanish 4/91, Italy 02 and Massachusetts strains. Each mutated residue was compared with the residue present in the same amino acid position in the other 3 Spanish genotypes. Mutated positions were mostly shared with 4/91 and Italy 02 strains, but distinct sharing rates were observed between the 5′ and 3′ regions within the *S1* gene. A total of 58 mutated residues were identified within the 200 amino acid 5′ terminal region. Only 1 (1.7%) out of the 58 mutated residues within this region was shared with 4/91 strains alone, whereas 33 (56.9%) were shared with Italy 02 isolates. The remaining positions were predominantly shared simultaneously with 4/91 and Italy 02 isolates. Very few unique mutations, 2 out of 58, were observed. When the 341 amino acid 3′ terminal region was analysed, 28 (87.5%) out of 32 identified mutated positions coincided with residues of 4/91 isolates, whereas only 1 (3.1%) coincided with Italy 02 isolates.

These observations correlated with distinct amino acid identities observed when both regions were compared separately among the three genotypes. Genotype IV had maximum amino acid identities with Italy 02 Spanish genotype (87.3%--95.4%) when the S1 200 Aa 5′ terminal region was compared, whereas amino acid identities in the same region with 4/91 Spanish genotype was much lower (68.8%--75.8%). On the contrary, when the 341 Aa 3′ end of the *S1* gene was compared, genotype IV showed maximum amino acid identities with 4/91 Spanish isolates (92.9%--97.9%), and lower similarities with Italy 02 Spanish isolates (88.8%--91.2%).

Positive selection pressure is detected in several amino acid positions within Italy 02 isolates, particularly within epitope region 2 {#section0035}
--------------------------------------------------------------------------------------------------------------------------------------

The average d~S~/d~N~ ratio within the 13 Spanish isolates of the 4/91 genotype was estimated to be 3.43, whereas within the Italy 02 Spanish isolates was 1.97. To identify regions or specific positions within the *S1* gene under positive selection, the d~N~  − d~S~ difference per codon was calculated for the Spanish Italy 02 isolates. The resulting graphic of the d~N~  − d~S~ difference plotted against entropy values for the initial 150 amino acid positions of Spanish Italy 02 isolates is shown in [Fig. 2](#fig2){ref-type="fig"} . Clearly, amino acid positions with positive d~N~  − d~S~ values also showed positive entropy values and were predominantly located within regions previously identified as virus-neutralizing and hemagglutination-inhibiting epitopes. Epitope 1 region contained 9 amino acid positions with positive d~N~  − d~S~ values, and five out of these 9 positions (amino acid residues 37, 42, 60, 62 and 63) were also fixed amino acid substitutions. Epitope 2 region contained 18 amino acid positions with positive d~N~  − d~S~ values, and five of them (residues 92, 129, 131, 141 and 143) became also fixed amino acid positions.Fig. 2Entropy rates and non-synonymous and synonymous difference (d~N~ − d~S~) plotted per each amino acid position for the first 150 amino acids of the *S1* gene. Both values were calculated using an alignment that included all Spanish field isolates of Italy 02 genotype.

Putative recombination events have been detected in three out of the four IBV genotypes in Spain {#section0040}
------------------------------------------------------------------------------------------------

A total of seven recombination events, including 16 recombination breakpoints, were identified among Spanish IBV field isolates. One recombination event, beginning at nucleotide 702 and ending at nucleotide 1389, was identified in both isolates of Spanish 4/91 genotype cluster II by five methods. A total of five recombination events were detected within Spanish Italy 02 isolates, however just only one of the six events was common to the 11 isolates. It began at nucleotide position 583 and ended at position 930, and it was detected by 5 out of the six methods implemented. Finally, one recombination event, beginning at nucleotide position 281 and ending at position 586, was detected in all three isolates of Spanish genotype IV by 4 of the 6 methods used. Phylogenetic analysis performed separately with sequence region comprised within recombination event and the remainder sequence regions generated different tree topologies in all three recombination events described ([Fig. 3](#fig3){ref-type="fig"} ).Fig. 3Phylogenetic analysis of putative recombinant breakpoint located at position 586 of Italy 02 and Genotype IV isolates. All twenty-six Spanish IBV field isolates were included in the comparison. Trees were generated by the Maximum Parsimony method with 1000 bootstraps in the Mega 3 package. 3a. Phylogenetic tree obtained when the S1 region from nt 1 to 586 in the alignment was used. Italy 02 and Genotype IV (in bold letters) isolates were clustered together in the same phylogenetic group. 3b. Phylogenetic tree obtained when the S1 region from nt 586 to 1623 in the alignment was used. Genotype IV isolates (in bold letters) were grouped with Spanish 4/91 cluster 1 isolates, whereas Spanish Italy 02 isolates formed an own phylogenetic cluster.

Cross-over sites were not homogeneously distributed within *S1* gene sequences. Eleven out of 16 breakpoints identified within *S1* gene sequences of Spanish field isolates were concentrated in the half 5′ terminal region. Particularly two regions comprised between 100 and 200 nucleotide positions and 400 and 600 nucleotide positions concentrated 7 out of the 16 cross-over sites. Thus, detailed sequence analysis of these regions among all Spanish isolates was carried out to identify sequence motifs, particularly IBV intergenic sequences (IGs) CTTAACA and CTTAACAA, which might have facilitated RNA--RNA recombination. All Spanish isolates included within genotype IV and Italy 02 genotypes showed IGs CTTAACA twice within *S1* gene, at nucleotide positions 370 and 445, with the exception of Spanish isolate Spain/05/21 that only showed it once at nucleotide position 445. Any of the Spanish isolates of 4/91 genotype neither Massachusetts genotype included this motif within *S1* gene sequence. Nucleotide sequence CTTAACAA was only found in genotype IV isolates and two Italy 02 isolates, Spain/97/314 and Spain/98/313, between nucleotide positions 440 and 450. Any of the other Spanish isolates had this motif within *S1* gene sequences.

Antigenic relatedness studies of the field isolates Spain/99/319 and Spain/99/325 {#section0045}
---------------------------------------------------------------------------------

To further serologically characterize Spanish IBV isolates, two Spanish field isolates Spain/99/319 and Spain/99/325 included in genotype 1 cluster 1 and genotype 4 respectively were selected to assess VN assay [Fig. 4](#fig4){ref-type="fig"} . Antigenic relatedness and neutralizing indexes are summarized in [Table 2](#tbl2){ref-type="table"} .Fig. 4Phylogenetic analysis of putative recombinant breakpoint located at position 700 of Spanish 4791 cluster 2 isolates. All twenty-six Spanish IBV field isolates were included in the comparison. Trees were generated by the Maximum Parsimony method with 1000 bootstraps in the Mega 3 package. 4a. Phylogenetic tree obtained when the S1 region from nt 1 to 700 in the alignment was used. Spanish 4/91 cluster 2 isolates (in bold letters) were grouped with the remaining Spanish 4/91 isolates. 4b. Phylogenetic tree obtained when the S1 region from nt 700 to 1623 in the alignment was used. Spanish 4/91 cluster 2 isolates (in bold letters) were clustered in an own phylogenetic branch closely related with Spanish Italy 02 isolates.Table 2Neutralizing index and antigenic relatedness of Spanish field isolates Spain/99/319 (Genotype I) and Spain/99/325 (Genotype IV) field isolates and the main reference IBV European serotypesVirus 1Virus 2Neutralizing index virus 1[a](#tblfn5){ref-type="table-fn"}Neutralizing index virus 2[b](#tblfn6){ref-type="table-fn"}Antigenic relatedness (%)Spain/99/325[c](#tblfn7){ref-type="table-fn"}M410.60.623.2D2740.840.633.0D14660.60.624.34/910.80.626.3Spain/00/337[e](#tblfn9){ref-type="table-fn"}2.81.98**67.5**Spain/99/3190.81.747.3Spain/99/3252.92.9100.0Spain/99/319[d](#tblfn8){ref-type="table-fn"}M410.60.627.3D2741.20.646.3D14660.840.633.84/9130.6**59.8**Spain/00/3371.41.243.6Spain/99/3251.70.847.3Spain/99/3192.12.1100.0[^1][^2][^3][^4][^5][^6]

Discussion {#section0050}
==========

Since it was first described in the early nineties in UK, 4/91 IBV serotype spread over many other countries and became one of the most predominant serotypes in Europe ([@bib5], [@bib11], [@bib12], [@bib19], [@bib35]). The present study shows 4/91 as one of the most predominant genotypes also in Spain and demonstrates it has been circulating in our country since 1992. Previous studies of the degree of variation exhibited within the *S1* gene sequences of 4/91 serotype isolates reported maximum nucleotide and amino acid differences of 4% and 8% respectively ([@bib11]). In the present investigation, 4/91 Spanish isolates showed higher genetic divergences among them, and more interestingly they were split in two major phylogenetic clusters, suggesting that 4/91 genotype has gone through evident evolutive changes during these years in our country. Furthermore, cross VN results carried out with a field 4/91 Spanish isolate demonstrates that these unique evolutive processes contributed to greatly decrease the antigenic relatedness between the 4/91 Spanish field strains and the reference 4/91 serotype. Hence, these findings suggest that antigenic subtypes may be present in field and in the brink of arising as a new serotype, regardless of the level of genetic variation displayed.

It is particularly remarkable that two Spanish 4/91 strains isolated the same year practically showed the maximum divergence exhibited within one IBV genotype and furthermore, they were grouped in separate phylogenetic clusters. Although a very rapid evolutive rate from a common ancestor might have lead to a similar situation, no cumulative changes were observed among Spanish 4/91 isolates and unique amino acidic changes observed in one of these two groups were not shared by the other. Moreover, the average d~S~/d~N~ ratio for the whole *S1* gene was not suggestive of a high evolutive rate. Therefore, one possible explanation for this scenario would be that 4/91 strains isolated in Spain evolved from at least two distinct evolutive lineages probably originated in two different ancestors. Taking into account that both isolates assigned to Spanish 4/91 cluster 2 are the more recently isolated, a new reintroduction of 4/91 isolates in our country could be hypothesized as has been previously suspected in other countries ([@bib1]). On the other hand, based on the results of recombination analyses carried out in this study, the possibility that recombination processes might have been involved in the rapid evolution of the Spanish 4/91 cluster 2 giving rise to a new lineage cannot be excluded.

Interestingly, the present study also shows an important shift in virus subpopulation dynamics along time with a clear replacement of predominant genotypes in our country. Whereas 4/91 was the predominant genotype in Spain in the nineties, the situation took a turn at the end of that decade when the new Italy 02 genotype appeared and displaced the previous predominant genotype. High sequence divergences and the presence of cumulative changes observed within Spanish Italy 02 isolates further support a fast evolutionary rate of this serotype in our country. A wide variety of causes could have been driving the observed virus subpopulation replacement. However, we found strong evidences of the positive selection of mutations within the S1 epitope regions of Italy 02 isolates which suggest a selection pressure-driven evolution of this genotype in Spain. Evidently, some cautionary remarks should be considered as our analyses were only focused on the S1 protein gene, but selection pressures could have occurred in other regions within IBV genome. Therefore, to accurately discern the evolutionary history of this genotypic shift, whole genome studies should be carried out.

At this point an intriguing question comes out regarding factors contributing to create a positive selection pressure. Our data suggests positive selected mutations of Italy 02 might have lead these new isolates escaping the immune system. Evidences of positive selection pressures acting over specific residues within antigenic sites have been previously reported for other viruses against which partial cross protection is induced after infection or vaccination, similarly to what happens with IBV ([@bib20], [@bib21], [@bib22]). In this sense, it is noteworthy that at the late nineties, commercial vaccines against the 4/91 became available in Spain. Therefore, it is likely that vaccination implemented against 4/91 serotype was very successful in order to achieve an effective control of infections caused by this serotype in our country, based on the drastic reduction of 4/91 isolations from clinical cases. But on the other hand, it is tempting to speculate that the high immune pressure against 4/91 isolates might have provided an environment in which the novel variant genotype Italy 02 had higher fitness advantage contributing to a faster establishment and spreading of this serotype in Spain.

Another challenging aspect of IBV epidemiology in Spain is the emergence of the Genotype IV isolates and its relationship with Italy 02 genotype. Genotype IV was established as a new genotype based on the mosaic nature of its *S1* gene. VN studies revealed Italy 02 and Genotype IV as being subtypes within a common serotype. However, the restricted epidemiological relevance of genotype IV, all three isolates included within this genotype were isolated in 1999 and in the same geographic region, clearly indicates distinct fitness abilities among IBV isolates. Therefore, this finding demonstrates that new unknown IBV isolates are emerging constantly, but only those with advantageous features within a particular environment become established, whereas others disappear and remain unidentified.

The extent of recombination events among IBV field isolates has been poorly investigated, even though recombination is a well-known feature of IBV ([@bib8], [@bib27], [@bib30]). Our data suggests that recombination events might have been frequently involved in the evolution of IBV rather than sporadically. Interestingly, most of the recombinant breakpoints identified among Spanish IBV field isolates were clustered in restricted regions within the 5′ half part of the *S1* gene and involved Italy 02 isolates, suggesting the presence of sequence or structure motifs that could act as specific "hotspots". RNA sequences and structures that promote viral RNA recombination have been demonstrated in several viruses ([@bib6], [@bib37]). Particularly, IGs that are required for transcription acting as a slow-down and detaching signal for the transcription--replication complex have been speculated to promote recombination exchange of whole genes in IBV ([@bib4], [@bib15], [@bib30]). Based in our results, "IGs-like" motifs, that probably arose because random mutations, could have favoured recombination within specific sites in the *S1* gene, increasing the potential of Italy 02 genotype to undergo recombination processes.

There have been few scientific studies covering the genetic and antigenic variation within IBV serotypes and dynamics along time of IBV genotypes in a specific region ([@bib11], [@bib31], [@bib32], [@bib34]). Herein, we present one of the most comprehensive studies of the genetic variation and evolution within a population of IBV isolates. Molecular analyses have revealed that vaccination, despite greatly contributes to the control of specific genotypes, may create and advantageous environment leading to successful spreading of new genotypes. Furthermore, our results indicate that recombination might have been frequently involved in the emergence and evolution of IBV.

Materials and methods {#section0055}
=====================

Viruses and antisera {#section0060}
--------------------

Twenty-six field avian IBVs isolated between 1992 and 2005 in Spain were included in this study. Viruses were obtained from clinical cases submitted to Centre de Recerca en Sanitat Animal (CReSA), Centre de Sanitat Avícola de Catalunya i Aragó (CESAC) and Centro de Investigación en Sanidad Animal (CISA). Epidemiological information of these isolates is summarized in [Table 1](#tbl1){ref-type="table"} . All field viruses were isolated in specific pathogen-free (SPF) embryonated eggs, acquired from Charles Rivers Spafas (North Franklin, USA). Two commercial vaccines currently licensed for use in Spain, IB 4/91 and IB MA5, were also included in the study. The reference IBV serotypes M41, D274, D1466 and 4/91 and antisera against them to be used in the virus neutralization (VN) assay were purchased from the Animal Health Center (Deventer, The Netherlands). The Spanish field virus Spain/00/337, also used in the VN assay, had been previously isolated and characterized as belonging to the Italy 02 serotype in our laboratory ([@bib14]). To obtain virus stocks for VN assays, allantoic fluid from field isolates Spain/99/319 and Spain/99/325 and reference strains was harvested, frozen at − 80 C and then titrated in SPF chicken embryos. Endpoint dilutions and titres were determined by the Reed and Muench method ([@bib48]). Monospecific antisera against field isolates were obtained following the procedure previously described ([@bib14], [@bib16]).Table 1Epidemiologic information of Spanish field IBV isolates included in the studyIBV isolate[a](#tblfn1){ref-type="table-fn"}Year[b](#tblfn2){ref-type="table-fn"}LocationType of chickenAgeTissue[c](#tblfn3){ref-type="table-fn"}Accession numbersSpain/92/351992N/ABroilerN/ATrachea[DQ386091](DQ386091)Spain/92/511992N/ABroilerN/ATrachea[DQ064801](DQ064801)Spain/92/1851992N/ABroilerN/ATrachea[DQ386092](DQ386092)Spain/95/1931995N/ABroilerN/ATrachea[DQ386093](DQ386093)Spain/95/1941995N/ABroilerN/ATrachea[DQ064802](DQ064802)Spain/96/3121996CatalunyaBroiler55dTrachea[DQk064803](DQk064803)Spain/96/3301996GaliciaBroiler32dTrachea, kidney[DQ386094](DQ386094)Spain/96/3341996N/AN/AN/ATrachea[DQ064804](DQ064804)Spain/97/3071997CatalunyaBroiler43dTrachea[DQ064805](DQ064805)Spain/98/3081998ValenciaSlow growth35dTrachea[DQ064807](DQ064807)Spain/98/3151998ValenciaBroiler35dTrachea, kidney, cecal tonsil[DQ386095](DQ386095)Spain/98/3281998N/AN/AN/ATrachea, kidney[DQ386096](DQ386096)Spain/99/3161999CenterBroiler23dKidney[DQ064809](DQ064809)Spain/99/3191999CatalunyaSlow growth38dTrachea, cecal tonsil[DQ064810](DQ064810)Spain/99/3251999CenterBroiler40dKidney[DQ064811](DQ064811)Spain/99/3261999CenterBroiler40dKidney[DQ064812](DQ064812)Spain/99/3271999CatalunyaBroiler49dTrachea[DQ386097](DQ386097)Spain/00/3362000CatalunyaBroiler44dTrachea[DQ386098](DQ386098)Spain/00/3392000CatalunyaBroiler35dTrachea[DQ064815](DQ064815)Spain/02/262002NavarraBroiler47dN/A[DQ386099](DQ386099)Spain/04/222004CatalunyaBroiler49dTrachea[DQ386100](DQ386100)Spain/04/242004CatalunyaBroiler36dTrachea[DQ386101](DQ386101)Spain/04/2212004C. ManchaN/AN/AN/A[DQ386103](DQ386103)Spain/04/54382004CatalunyaBroiler49dTrachea[DQ386105](DQ386105)Spain/05/822005C. ManchaN/AN/AN/A[DQ386104](DQ386104)Spain/05/8662005MurciaBroiler41dTrachea[DQ386102](DQ386102)[^7][^8][^9][^10][^11]

RT-PCR and nucleotide sequencing {#section0065}
--------------------------------

RNA was extracted from 150 μl of allantoic fluid using Nucleospin RNA Virus Kit (Macherey-Nagel) according to manufacturer\'s instructions. The complete *S1* gene was amplified with oligonucleotides S1Uni2+ and IBP1- as previously described ([@bib2]). The 1800-bp RT-PCR products were purified by QIAquick gel extraction Kit and Minelute PCR purification Kit (Qiagen Inc.) following manufacturer\'s instructions. Sequencing of the whole *S1* gene was carried out using a combination of eight internal primers previously published ([@bib14]). Some modifications were implemented to primers S1PR2+, S1PR2--, S1PR5+ and S1PR6+ because several mismatches were detected in some isolates, preventing correct sequencing. Sequences of modified primers were S1PR2+nou (5′ TAGCCTACTTTGTTAATGGTA 3′), S1PR2--nou (5′ GTACCATTAACAAAGTAGGCTA 3′), S1PR5+nou (5′ TAGATACTTCAGGAGCCATAGACA 3′) and S1PR6+nou (5′ CCATAGACATATTTGTTGTTC 3′). Purified RT-PCR products were sequenced by the dideoxy-mediated chain-termination method using ABI PRISM BigDye® Terminator v3.1 Cycle Sequencing Kit (PE Biosystems) as described by the manufacturer. Sequences were analyzed with an automated nucleic acid analyzer (ABI PRISM 3100 Avant; PE Biosystems).

Nucleotide and amino acid deduced sequence analyses {#section0070}
---------------------------------------------------

Assembly of sequence contigs and sequence analysis were performed with the Bioedit v7.0.5 package. The twenty-six IBV Spanish field isolates, the two vaccine strains, and the reference IBV strains downloaded from the GenBank database were first aligned using ClustalW included in the Bioedit v7.0.5. Phylogenetic trees were inferred using a maximum likelihood (ML) algorithm with the Tree-Puzzle 5.2 software ([@bib43]). In all cases trees were estimated using the best fitting model of nucleotide substitution identified by Modeltest 3.8 ([@bib41]).

GenBank accession numbers {#section0075}
-------------------------

Nucleotide and amino acid deduced S1 sequences of reference IBV strains included in the comparisons were available in GenBank under the following accession numbers: Ark-99 ([L10384](L10384)); Beaudette ([X02342](X02342)); B1648 ([X87238](X87238)); De072 ([U77298](U77298)); D1466 ([M21971](M21971)); D207 ([M21969](M21969)); D274 ([X15832](X15832)); D3896 ([X52084](X52084)); FR-CR88061-88 ([AJ618986](AJ618986)); FR-85131-85 ([AJ618985](AJ618985)); FR-96047-94 ([AJ818987](AJ818987)); Gray ([L14069](L14069)); Holte ([L18988](L18988)); H120 ([M21970](M21970)); H52 ([AF352315](AF352315)); Italy 02 ([AJ457137](AJ457137)); IR-1061-PH ([AY544778](AY544778)); IR-1062-GA ([AY544777](AY544777)); IR-3654-VM ([AY544776](AY544776)); JMK ([L14070](L14070)); M41 ([X04722](X04722)); Spain/97/314 ([DQ064806](DQ064806)); Spain/98/313 ([DQ064808](DQ064808)); Spain/00/337 ([DQ064813](DQ064813)) and Spain/00/338 ([DQ064814](DQ064814)); UK/2/91 ([Z83976](Z83976)); UK/3/91 ([Z83977](Z83977)); UK/5/91 ([Z83978](Z83978)); UK/7/91 ([Z83975](Z83975)); UK/7/93 ([Z83979](Z83979)); UK-1233-95 ([AJ618984](AJ618984)); 4/91 pathogenic ([AF093794](AF093794)).

Selection pressure analysis on the *S1* gene {#section0080}
--------------------------------------------

Potential selective pressures along the *S1* gene of major Spanish genotypes isolates were assessed first by calculating the average ratio of synonymous substitutions per synonymous site (d~S~) to non-synonymous substitutions per non-synonymous site (d~N~) (d~S~/d~N~). In addition, to detect specific residues within the *S1* gene under strong selective pressure the subtraction of synonymous from non-synonymous nucleotide changes (d~N~  − d~S~) per codon was calculated and plotted versus the amino acid sequence entropy, that is a measure of the lack of predictability at each position in the alignment and gives an idea of the amount of variability through a column in the alignment ([@bib44]). Both, average d~S~/d~N~ ratio and codon d~N~ and d~S~ were calculated with the SNAP web utility (<http://hiv-web.lanl.gov/content/hiv-db/SNAP/WEBSNAP/SNAP.html>). Amino acid entropy was calculated with BioEdit v7.0.5 software.

Recombination analysis {#section0085}
----------------------

To determine whether recombination events had been involved in the evolution of Spanish IBV isolates, and to identify putative recombination breakpoints in the *S1* gene, RDP v2.0 software was used ([@bib33]). Only Spanish field isolates were included in the study because the objective was to investigate the extent of recombination events in field. All field Spanish isolates were aligned using ClustalW program implemented in BioEdit v7.0.5 package. Then, six methods implemented in the RDP v2.0 software package, including RDP, Bootscan, GENECONV, Maxchi, Chimaera and SiScan were employed to identify recombinant breakpoints ([@bib17], [@bib39], [@bib40], [@bib42]). General settings used for all methods were as follows: window size = 20, highest acceptable *P* value = 0.001 and Bonferroni correction. Only recombination breakpoints detected by more than three methods were considered. Also, once potential recombination events were identified, sequence alignment was split at that point and phylogenetic analysis of the two regions was performed to evaluate conflicting evolutionary histories of both regions. Phylogenetic trees were constructed by using a maximum parsimony method with 1000 bootstraps ([@bib28]). Same methods and software have been previously used in recombination studies with SARS ([@bib53]).

Cross-VN analysis {#section0090}
-----------------

To determine the antigenic relationships among the field Spanish isolates Spain/99/319 and Spain/99/325 and IBV reference strains M41, D274, 4/91, D1466 and Italy 02, reciprocal beta VN assays (diluted-serum constant-virus) were performed as described by Thayer and Beard ([@bib47]). Four-fold serial dilutions of each antiserum, and 100 EID~50~ 0.1 ml^− 1^ of each virus were used. Antiserum, virus and negative controls were carried out in each assay. Endpoint titres were calculated by the Reed and Müench method ([@bib48]). The VN titres against homologous and heterologous virus were used to calculate the antigenic relatedness (*r*-values) by the formula of Archetti and Horsfall ([@bib3]).

[^1]: Maximum antigenic relatedness obtained for each isolate is indicated in bold letters.

[^2]: Neutralizing index obtained from antisera of virus 1 against virus 2.

[^3]: Neatruazing index obtained from antisera of virus 2 against virus 1.

[^4]: Spanish isolate representative from Genotype IV.

[^5]: Spanish isolate representative from Genotype I (4/91 Spanish isolate).

[^6]: Spanish field isolate previously demonstrated to belong to Italy 02 serotype (Dolz et al., [@bib14]).

[^7]: Isolates are sorted by year of isolation and then by isolate number. The GenBank accession number of the obtained *S1* genes sequences for each isolate is included.

[^8]: N/A = Data not available.

[^9]: Isolates have been named as proposed by Cavanagh (2002).

[^10]: Year of isolation.

[^11]: Tissues used for IBV isolation.
